Low Dose Celecoxib Combined with Clozapine for Treatment of Schizophrenia: A Double Blind Randomized Clinical Trial

سال انتشار: 1394
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 98

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJTMGH-3-1_004

تاریخ نمایه سازی: 27 تیر 1402

چکیده مقاله:

Introduction: Higher levels of pro-inflammatory cytokines in schizophrenia have suggested that dysfunctions of the immune system may play a role in this disabling condition. The current study was performed to discover if low dose celecoxib combined with clozapine may improve symptoms of schizophrenia or not. Methods: In a double-blind randomized clinical trial, ۴۰ patients with non- treatment resistance schizophrenia were allocated into two groups. The experimental group received flexible and low dose clozapine plus ۲۰۰ mg/day of celecoxib for ۴ weeks, while the control group received clozapine plus placebo. Experimental and control groups were similar in terms of age, gender, clozapine mean dosage and severity of schizophrenic symptoms at baseline. Main outcomes were severity of schizophrenia symptoms measured by the Positive and Negative Syndrome Scale (PANSS) at baseline followed by the second and fourth weeks. Results: Although both groups experienced significant improvement in all PANSS sub-scales in the second and fourth weeks (P<۰.۰۰۱), the differences between the two groups did not reach significance (P>۰.۰۵). Conclusion: Our findings did not support the findings of prior studies that report a significant effect for celecoxib combined with atypical antipsychotics. Such inconsistency may be due to statistical power, drug interactions between clozapine and celecoxib, and the low dose of celecoxib used in this study. Future research is needed on the role of anti-inflammatory medications as adds-on treatments for schizophrenia.

نویسندگان

Roya Samadi

Department of Psychiatry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Ali Akhondpour Manteghi

Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Mehri Baghban Haghighi

Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Amin Azhari

Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Shervin Assari

Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Sadock BJ, Sadock VA. Kaplan & Sadock’s comprehensive textbook of ...
  • Müller N, Ackenheil M. Psychoneuroimmunology and the cytokine action in ...
  • Monji A. The neuroinflammation hypothesis of psychiatric disorders. Seishin Shinkeigaku ...
  • Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, ...
  • Licino J, Seibyl JP, Altemus M, Charney DS, Krystal JH. ...
  • McAllister CG, Van Kammen DP, Rehn TJ, Miller AL, Gurklis ...
  • Müller N, Dobmeier P, Empl M, Riedel M, Schwarz M, ...
  • Van Kammen DP, McAllister-Sistilli CG, Kelley ME. Relationship between immune ...
  • Müller N, Ulmschneider M, Scheppach C, Schwarz MJ, Ackenheil M, ...
  • Müller N, Riedel M, Schwarz MJ, Engel RR. Clinical effects ...
  • Müller N, Strassnig M, Schwarz MJ, Ulmschneider M, Riedel M. ...
  • Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-۲ contributes ...
  • Müller N, Riedel M, Scheppach C, Brandstätter B, Sokullu S, ...
  • Müller N, Empl M, Riedel M, Schwarz M, Ackenheil M. ...
  • Lin A, Kenis G, Bignotti S, Tura GJ, De Jong ...
  • Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. ...
  • Yermakova A, Banion MK. Cyclooxygenases in the Central Nervous System: ...
  • Meyer U, Schwarz MJ, Müller N. Inflammatory processes in schizo-phrenia: ...
  • Hochberg MC. COX-۲ selective inhibitors in the treatment of arthri-tis: ...
  • McGeer PL. COX –۲ inhibitors: rationale and therapeutic potential for ...
  • Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Ab-basi ...
  • Mizuno M, Sotoyama H, Narita E, Kawamura H, Namba H, ...
  • Rapaport MH, Delrahim KK, Bresee CJ, Maddux RE, Ahmadpour O, ...
  • Stolk P, Souverein PC, Leufkens HG, Weil JG, Egberts AC, ...
  • Ginovart N, Kapur S. Role of dopamine d(۲) receptors for ...
  • Partitt K. Martindale: the complete drug reference. ۳۲nd ed. Massa-chusetts: ...
  • Røge R, Møller BK, Andersen CR, Correll CU, Nielsen J. ...
  • Meltzer HY. Update on Typical and Atypical Antipsychotic Drugs. Annu ...
  • Hardman IG, Limbard LE. Goodman & Gilman’s the Pharmacologi-cal Basis ...
  • Meltzer HY, Massey BW, Horiguchi M. Serotonin receptors as tar-gets ...
  • Suzuki T, Remington G, Mulsant BH, et al. Treatment resistant ...
  • Baik EJ, Kim EJ, Lee SH, Moon C. Cyclo-oxygenase-۲ selective ...
  • Lantz MS, Giambanco V. Acute onset of auditory hallucination after ...
  • Kay SR, Fiszbein A, Opler LA: The Positive and Negative ...
  • Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of ...
  • Kianmanesh S, Jenaabadi H. The study of difference between the ...
  • Müller N, Riedel M, Schwarz MJ. Psychotropic effects of COX-۲ ...
  • Bresee CJ, Delrahim K, Maddux RE, Dolnak D, Ahmadpour O, ...
  • Bian Q, Kato T, Monji A, Hashioka S, Mizoguchi Y, ...
  • Jann MW, Saklad SR, Ereshefsky L, Richards AL, Harrington CA, ...
  • Dysken MW, Cumming RJ, Channon RA, Davis JM. Drug interac-tion ...
  • Kulhanek F, Linde OK, Meisenberg G. Precipitation of antipsychotic drugs ...
  • Bowen S, Taylor KM, Gibb IA. Effect of coffee and ...
  • Sommer IE, de Witte L, Begemann M, Kahn RS. Nonsteroidal ...
  • Krebs M, Leopold K, Hinzpeter A, Schaefer M. Neuroprotective agents ...
  • نمایش کامل مراجع